Opportunities & Announcements

All NIAID-relevant grant funding opportunity announcements (FOAs) are listed here. Find amendments inside the FOAs. Subscribe for Email Updates for our opportunities. Also see NIAID Contract Solicitations or Find a Foundation or Other Funding Source outside NIH.

Showing results filtered by:
Title Activity CodeSort descending Posting Date Expiration Date
Successor-in-Interest (Type 6 Parent Clinical Trial Optional)- PA-18-589 January 26, 2018 January 26, 2021
Change of Grantee Organization (Type 7 Parent Clinical Trial Optional)- PA-18-590 January 26, 2018 January 26, 2021
Global Infectious Disease Research Training Program (D43 Clinical Trial Optional)- PAR-18-840 D43 June 26, 2018 July 26, 2019
Ruth L. Kirschstein National Research Service Award (NRSA) Individual Fellowship for Students at Institutions with NIH-Funded Institutional Predoctoral Dual-Degree Training Programs (Parent F30)- PA-18-668 F30 February 16, 2018 January 8, 2021
Ruth L. Kirschstein National Research Service Award (NRSA)Individual Fellowship for Students at Institutions Without NIH-Funded Institutional Predoctoral Dual-Degree Training Programs (Parent F30)- PA-18-673 F30 February 20, 2018 January 8, 2021
Ruth L. Kirschstein National Research Service Award (NRSA) Individual Predoctoral Fellowship to Promote Diversity in Health-Related Research (Parent F31)- PA-18-666 F31 February 15, 2018 January 8, 2021
Ruth L. Kirschstein National Research Service Award (NRSA) Individual Predoctoral Fellowship (Parent F31)- PA-18-671 F31 February 16, 2018 January 8, 2021
Ruth L. Kirschstein National Research Service Award (NRSA) Individual Postdoctoral Fellowship (Parent F32)- PA-18-670 F32 February 16, 2018 January 8, 2021
Global Infectious Disease Research Administration Development Award for Low- and Middle-Income Country Institutions (G11 Clinical Trial Not Allowed)- PAR-18-335 G11 October 31, 2017 August 1, 2020
Mentored Research Scientist Development Award (Parent K01 - Independent Clinical Trial Not Allowed)- PA-19-126 K01 December 20, 2018 January 8, 2022
Mentored Clinical Scientist Research Career Development Award (Parent K08 Independent Clinical Trial Not Allowed)- PA-19-117 K08 December 20, 2018 January 8, 2022
NIAID Career Transition Award- PAR-16-434 K22 September 16, 2016 September 8, 2019
Mentored Patient-Oriented Research Career Development Award (Parent K23 Independent Clinical Trial Not Allowed)- PA-19-119 K23 December 20, 2018 January 8, 2022
Midcareer Investigator Award in Patient-Oriented Research (Parent K24 Independent Clinical Trial Required)- PA-19-121 K24 December 20, 2018 January 8, 2022
Midcareer Investigator Award in Patient-Oriented Research (Parent K24 Independent Clinical Trial Not Allowed)- PA-19-122 K24 December 20, 2018 January 8, 2022
Mentored Quantitative Research Development Award (Parent K25 - Independent Clinical Trial Not Allowed)- PA-19-124 K25 December 20, 2018 January 8, 2022
NIAID Physician-Scientist Pathway to Independence Award (K99/R00)- PAR-17-329 K99/R00 July 20, 2017 May 8, 2020
NIH Pathway to Independence Award (Parent K99/R00 - Independent Clinical Trial Not Allowed)- PA-19-130 K99/R00 December 20, 2018 January 8, 2022
NIAID Physician-Scientist Pathway to Independence Award (K99/R00 Clinical Trial Required)- PAR-18-679 K99/R00 February 23, 2018 May 8, 2020
HIV Vaccine Research and Design (HIVRAD) Program (P01 Clinical Trial Not Allowed)- PAR-18-319 P01 October 13, 2017 March 14, 2020
NIAID Investigator-Initiated Program Project Applications- PAR-16-413 P01 August 18, 2016 September 8, 2019
Centers for AIDS Research (P30)- PAR-17-237 P30 March 30, 2017 August 18, 2019
Developmental Centers for AIDS Research (P30)- PAR-17-238 P30 March 30, 2017 August 18, 2019
Research to Advance HBV Cure: HIV/HBV Co-Infection and HBV Mono-infection (R01 Clinical Trial Not Allowed)- PAS-19-097 R01 November 29, 2018 January 8, 2022
Advancing Research Needed to Develop a Universal Influenza Vaccine (R01 Clinical Trial Not Allowed)- PA-18-859 R01 July 18, 2018 September 8, 2021
Trophoblast Differentiation and Function (R01)- PA-16-445 R01 September 23, 2016 January 8, 2020
Research on Transgender Health (R01)- PA-17-478 R01 September 8, 2017 January 8, 2021
Improving Patient Adherence to Treatment and Prevention Regimens to Promote Health (R01 Clinical Trial Optional)- PA-18-722 R01 March 28, 2018 May 8, 2021
Dissemination and Implementation Research in Health (R01)- PAR-16-238 R01 May 10, 2016 May 8, 2019
Modeling of Infectious Disease Agent Study Research Projects (R01)- PA-16-107 R01 February 22, 2016 May 8, 2019
Research Project Grant (Parent R01 Clinical Trial Required)- PA-19-055 R01 November 5, 2018 January 8, 2022
Therapeutic Strategies for the Converging TB/T2DM/HIV Epidemics (R01)- PA-17-283 R01 May 12, 2017 September 8, 2020
U.S.-Brazil Collaborative Biomedical Research Program (R01 Clinical Trial Optional)- RFA-AI-18-054 R01 December 4, 2018 March 9, 2019
Research Project Grant (Parent R01 Clinical Trial Not Allowed)- PA-19-056 R01 November 5, 2018 January 8, 2022
Eradication of HIV-1 From Central Nervous System Reservoirs (R01)- PA-17-084 R01 December 13, 2016 January 8, 2020
Imaging the Persistent HIV Reservoir (R01)- PA-17-305 R01 June 6, 2017 May 8, 2020
Investigator Initiated Extended Clinical Trial (R01 Clinical Trial Required)- PAR-18-630 R01 February 5, 2018 December 7, 2019
Research to Advance Vaccine Safety (R01 Clinical Trial Not Allowed)- PA-18-873 R01 July 24, 2018 September 8, 2021
Dissemination and Implementation Research in Health (R01 Clinical Trial Optional)- PAR-18-007 R01 November 3, 2017 May 8, 2019
Generating New Insights and Mechanistic Understanding of Antibiotic Resistance Development (R01 Clinical Trial Not Allowed)- PA-18-725 R01 March 28, 2018 May 8, 2021
Improvement of Animal Models for Stem Cell-Based Regenerative Medicine (R01)- PAR-16-093 R01 February 9, 2016 May 8, 2019
HIV-1 Infection of the Central Nervous System (R01)- PA-17-100 R01 January 5, 2017 January 8, 2020
Processing and Presentation of Non-Conventional MHC Ligands (R01 Clinical Trial Not Allowed)- PA-19-067 R01 November 13, 2018 January 8, 2022
CNS-Targeted Drug Delivery Strategies for HIV (R01 Clinical Trial Not Allowed) - PAR-18-895 R01 August 8, 2018 January 8, 2021
Fc Receptor (FcR) and Antibody Effector Function in HIV Vaccine Discovery (R01)- PA-17-113 R01 January 9, 2017 January 8, 2020
Transformative Research Award for the INCLUDE (Investigation of Co-occurring Conditions across the Lifespan to Understand Down syndrome) Project (R01 Clinical Trial Not Allowed)- RFA-OD-19-016 R01 February 5, 2019 March 15, 2019
Research on the Health of Transgender and Gender Nonconforming Populations (R01 Clinical Trial Optional)- PA-18-729 R01 March 28, 2018 January 8, 2021
Novel Approaches to Understanding, Preventing, and Treating Lyme Disease and Tickborne Coinfections (R01)- PA-16-243 R01 May 9, 2016 September 8, 2019
Single-Cell Multi-Omics of HIV Persistence (R01 Clinical Trial Not Allowed)- RFA-AI-18-053 R01 November 13, 2018 March 14, 2019
Novel Biomarkers for the Development of HIV Incidence Assays with Improved Specificity (R01 Clinical Trial Optional)- PA-18-753 R01 April 11, 2018 May 8, 2021
Developmentally Tailored HIV Prevention and Care Research for Adolescents and Young Adults (R01 Clinical Trial Optional)- PA-18-651 R01 February 12, 2018 January 8, 2021
Serious Adverse Drug Reaction Research (R01)- PAR-16-275 R01 May 19, 2016 September 8, 2019
Getting to Zero: Understanding HIV Viral Suppression and Transmission in the United States (R01 Clinical Trial Not Allowed)- PAR-18-411 R01 November 16, 2017 March 14, 2020
Assay development and screening for discovery of chemical probes or therapeutic agents (R01)- PAR-17-438 R01 July 27, 2017 September 8, 2020
International Research in Infectious Diseases, including AIDS (R01) - PAR-17-142 R01 January 27, 2017 August 23, 2019
Accelerating Malaria Vaccine Discovery (R01 Clinical Trial Not Allowed)- PA-19-077 R01 November 26, 2018 January 8, 2022
Harnessing Big Data to Halt HIV (R01 Clinical Trial Optional)- PAR-18-764 R01 April 20, 2018 May 8, 2021
Advancing Development of Rapid Fungal Diagnostics (R01 Clinical Trial Not Allowed)- PA-19-080 R01 November 26, 2018 January 8, 2022
NK Cells to Induce Immunological Memory to Prevent HIV Infection (R01)- PA-17-114 R01 January 9, 2017 January 8, 2020
Understanding the Early Development of the Immune System (R01 - Clinical Trial Not Allowed)- PAR-18-333 R01 October 25, 2017 December 6, 2019
Approaches for Understanding Disease Mechanisms and Improving Outcomes in TB Meningitis (TBM) (R01 Clinical Trial Not Allowed)- PAR-18-822 R01 June 7, 2018 September 5, 2020
Novel approaches to understand, prevent, treat, and diagnose coccidioidomycosis (Valley Fever) and other select endemic fungal infections (R01 Clinical Trial Not Allowed)- PA-19-082 R01 November 26, 2018 January 8, 2022
Bioengineering Research Grants (BRG) (R01 Clinical Trial Not Allowed)- PAR-19-158 R01 January 8, 2019 January 8, 2022
Engaging Men in HIV Testing, Prevention, and Care (R01 Clinical Trial Optional)- PA-19-042 R01 November 1, 2018 September 8, 2021
Molecular and Genetic Characterization of Inborn Errors of Immunity (R01 Clinical Trial Not Allowed)- PAR-19-078 R01 November 26, 2018 January 8, 2022
Innovation for HIV Vaccine Discovery (R01)- PAR-17-263 R01 April 25, 2017 August 2, 2019
Investigations on Primary Immunodeficiency Diseases/Inborn Errors of Immunity (R01 Clinical Trial Not Allowed)- PAR-18-712 R01 March 15, 2018 May 8, 2021
Modeling of Infectious Disease Agent Study Research Projects (R01)- PAR-17-267 R01 May 5, 2017 May 8, 2019
Control of Sexually Transmitted Infections (STIs) Through a Comprehensive Understanding of the Natural History of Infection (R01 Clinical Trial Not Allowed)- PA-19-096 R01 November 29, 2018 January 8, 2022
Indo-U.S. Vaccine Action Program (VAP) Small Research Grant Program (R03)- PA-16-163 R03 April 4, 2016 May 8, 2019
Small Grants on Primary Immunodeficiency Diseases (R03)- PAR-17-332 R03 July 21, 2017 July 17, 2019
Limited Competition: Small Research Grant Program for NIAID K01/K08/K23 Recipients (R03) - PAR-17-439 R03 July 28, 2017 September 8, 2020
Ethical, Legal, and Social Implications (ELSI) of Genomics Small Research Grant Program (R03)- PA-17-445 R03 August 1, 2017 September 8, 2020
NIH Small Research Grant Program (Parent R03 Clinical Trial Not Allowed)- PA-19-052 R03 November 5, 2018 January 8, 2022
NIH Support for Conferences and Scientific Meetings (Parent R13 Clinical Trial Not Allowed)- PA-18-648 R13 February 9, 2018 January 8, 2021
Academic Research Enhancement Award for Undergraduate-Focused Institutions (R15 Clinical Trial Not Allowed)- PAR-18-714 R15 March 14, 2018 May 8, 2021
Research Enhancement Award Program (REAP) for Health Professional Schools and Graduate Schools (R15 Clinical Trial Not Allowed)- PAR-19-134 R15 December 21, 2018 January 8, 2022
NIH Exploratory/Developmental Research Grant Program (Parent R21 Clinical Trial Required)- PA-19-054 R21 November 5, 2018 January 8, 2022
Immune Response to Arthropod Blood Feeding (R21 Clinical Trial Not Allowed)- PAR-18-860 R21 July 19, 2018 October 16, 2020
Improving Patient Adherence to Treatment and Prevention Regimens to Promote Health (R21 Clinical Trial Optional)- PA-18-723 R21 March 28, 2018 May 8, 2021
Dissemination and Implementation Research in Health (R21)- PAR-16-236 R21 May 10, 2016 May 8, 2019
Therapeutic Strategies for the Converging TB/T2DM/HIV Epidemics (R21)- PA-17-282 R21 May 12, 2017 September 8, 2020
Research to Advance Vaccine Safety (R21 Clinical Trial Not Allowed)- PA-18-872 R21 July 24, 2018 September 8, 2021
Generating New Insights and Mechanistic Understanding of Antibiotic Resistance Development (R21 Clinical Trial Not Allowed) - PA-18-724 R21 March 28, 2018 May 8, 2021
Processing and Presentation of Non-Conventional MHC Ligands (R21 Clinical Trial Not Allowed)- PA-19-066 R21 November 13, 2018 January 8, 2022
Optimizing HIV Phylodynamics to Target and Interrogate Clusters (OPTICs) (R21)- PA-17-306 R21 June 7, 2017 May 8, 2020
Dissemination and Implementation Research in Health (R21 Clinical Trial Optional)- PAR-18-017 R21 November 3, 2017 May 8, 2019
Research on the Health of Transgender and Gender Nonconforming Populations (R21 Clinical Trial Optional)- PA-18-728 R21 March 28, 2018 January 8, 2021
Improvement of Animal Models for Stem Cell-Based Regenerative Medicine (R21)- PAR-16-094 R21 February 9, 2016 May 8, 2019
Secondary Analysis of Existing Datasets for Advancing Infectious Disease Research (R21 Clinical Trial Not Allowed)- PA-19-068 R21 November 13, 2018 January 8, 2022
Trophoblast Differentiation and Function (R21 Clinical Trial Optional)- PA-18-047 R21 November 15, 2017 January 8, 2020
Zika Virus (ZIKV) Complications (R21 Clinical Trial Optional)- PA-18-048 R21 November 15, 2017 January 8, 2020
Novel Approaches to Understanding, Preventing, and Treating Lyme Disease and Tickborne Coinfections (R21)- PA-16-244 R21 May 9, 2016 September 8, 2019
Exploratory/Developmental Investigations on Primary Immunodeficiency Diseases (R21)- PAR-17-333 R21 July 21, 2017 July 17, 2019
Novel Biomarkers for the Development of HIV Incidence Assays with Improved Specificity (R21 Clinical Trial Not Allowed)- PA-18-754 R21 April 11, 2018 May 8, 2021
Developmentally Tailored HIV Prevention and Care Research for Adolescents and Young Adults (R21 Clinical Trial Not Allowed)- PA-18-652 R21 February 12, 2018 January 8, 2021
Characterization of Mycobacterial Induced Immunity in HIV-infected and Uninfected Individuals (R21 Clinical Trial Not Allowed)- PAR-18-923 R21 September 17, 2018 January 15, 2021
Collaborative Cross (CC) Mouse Model Generation and Discovery of Immunoregulatory Mechanisms (R21 Clinical Trials Not Allowed)- PAR-18-781 R21 May 11, 2018 September 10, 2020
Ethical, Legal, and Social Implications (ELSI) of Genomics Exploratory/Developmental Research Grant Program (R21)- PA-17-446 R21 August 1, 2017 September 8, 2020
Advancing Development of Rapid Fungal Diagnostics (R21 Clinical Trial Not Allowed)- PA-19-081 R21 November 26, 2018 January 8, 2022
Fc-Dependent Mechanisms of Antibody-Mediated Killing (R21 Clinical Trial Not Allowed)- PA-19-020 R21 October 5, 2018 January 8, 2022
Serious Adverse Drug Reaction Research (R21)- PAR-16-274 R21 May 19, 2016 September 8, 2019
Novel approaches to understand, prevent, treat, and diagnose coccidioidomycosis (Valley Fever) and other select endemic fungal infections (R21 Clinical Trial Not Allowed)- PA-19-083 R21 November 26, 2018 January 8, 2022
Engaging Men in HIV Testing, Prevention, and Care (R21 Clinical Trial Optional)- PA-19-050 R21 November 1, 2018 September 8, 2021
Molecular and Genetic Characterization of Inborn Errors of Immunity (R21 Clinical Trial Not Allowed)- PAR-19-079 R21 November 26, 2018 January 8, 2022
Advancing Research Needed to Develop a Universal Influenza Vaccine (R21 Clinical Trial Not Allowed)- PA-18-858 R21 July 18, 2018 September 8, 2021
Research on Transgender Health (R21) - PA-17-477 R21 September 8, 2017 January 8, 2021
NIH Exploratory/Developmental Research Grant Program (Parent R21 Clinical Trial Not Allowed)- PA-19-053 R21 November 5, 2018 January 8, 2022
NIAID Resource-Related Research Projects- PAR-16-412 R24 August 18, 2016 September 8, 2019
NIAID Research Education Program (R25)- PAR-17-455 R25 August 11, 2017 December 6, 2019
NIAID Clinical Trial Planning Grant- PAR-16-272 R34 May 18, 2016 May 14, 2019
Stimulating Access to Research in Residency (StARR) (R38)- RFA-HL-18-023 R38 August 23, 2017 May 13, 2020
Platform Delivery Technologies for Nucleic Acid Therapeutics (R41/R42)- PAR-17-036 R41/R42 October 27, 2016 September 6, 2019
Strategies for the Improvement of HIV Envelope Protein Expression and Yield (R41/R42)- PA-16-182 R41/R42 April 12, 2016 April 6, 2019
The Use of mRNA for an HIV Envelope Vaccine (R41/R42)- PA-16-208 R41/R42 April 19, 2016 April 6, 2019
PHS 2018-02 Omnibus Solicitation of the NIH, CDC, and FDA for Small Business Technology Transfer Grant Applications (Parent STTR [R41/R42] Clinical Trial Not Allowed)- PA-18-575 R41/R42 January 16, 2018 April 6, 2019
Platform Delivery Technologies for Nucleic Acid Therapeutics (R43/R44)- PAR-17-035 R43/R44 October 27, 2016 September 6, 2019
The Use of mRNA for an HIV Envelope Vaccine (R43/R44)- PA-16-207 R43/R44 April 19, 2016 April 6, 2019
Strategies for the Improvement of HIV Envelope Protein Expression and Yield (R43/R44)- PA-16-184 R43/R44 April 12, 2016 April 6, 2019
Tools for Cell Line Identification- PA-16-186 R43/R44 April 15, 2016 April 6, 2019
Radiological/Nuclear Medical Countermeasure Product Development Program (SBIR) (R43/R44 Clinical Trial Not Allowed)- PA-18-525 R43/R44 December 19, 2017 January 6, 2021
PHS 2018-02 Omnibus Solicitation of the NIH, CDC, and FDA for Small Business Innovation Research Grant Applications (Parent SBIR [R43/R44] Clinical Trial Not Allowed)- PA-18-574 R43/R44 January 16, 2018 April 6, 2019
Long-acting Drug Delivery Systems for ART Optimization in HIV-1 Infected Children (R61/R33 Clinical Trial Not Allowed)- RFA-AI-18-057 R61/R33 November 20, 2018 March 14, 2019
Detection of HIV for Self-Testing (R61/R33)- PAR-17-471 R61/R33 August 25, 2017 December 7, 2019
Support of Competitive Research (SCORE) Research Advancement Award - PAR-16-439 SC1 September 21, 2016 September 8, 2019
Support of Competitive Research (SCORE) Pilot Project Award- PAR-16-438 SC2 September 21, 2016 September 8, 2019
Research Supplements to Promote Re-Entry into Biomedical and Behavioral Research Careers (Admin Supp - Clinical Trial Not Allowed )- PA-18-592 Supp January 25, 2018 September 8, 2021
Research Supplements to Promote Diversity in Health-Related Research (Admin Supp - Clinical Trial Not Allowed)- PA-18-906 Supp August 22, 2018 September 8, 2021
Primary Caregiver Technical Assistance Supplements (PCTAS) (Clinical Trial Optional Admin Supp)- PA-18-926 Supp September 18, 2018 April 2, 2021
Urgent Competitive Revision to Existing NIH Grants and Cooperative Agreements (Urgent Supplement - Clinical Trial Optional)- PA-18-935 Supp October 3, 2018 January 25, 2022
Administrative Supplements for Research on Dietary Supplements (Admin Supp - Clinical Trial Not Allowed)- PA-18-817 Supp June 5, 2018 April 16, 2020
Administrative Supplements to Promote Diversity in Small Businesses-SBIR/STTR (Admin Supp Clinical Trial Not Allowed)- PA-18-837 Supp June 20, 2018 September 5, 2021
Administrative Supplement for Research on Sex/Gender Influences (Admin Supp Clinical Trial Optional)- PA-19-165 Supp January 18, 2019 February 21, 2019
Research Supplements to Promote Diversity in Health-Related Research (Admin Supp - Clinical Trial Not Allowed)- PA-18-586 Supp January 25, 2018 September 8, 2021
Administrative Supplements to Existing NIH Grants and Cooperative Agreements (Parent Admin Supp - Clinical Trial Optional)- PA-18-591 Supp January 25, 2018 January 26, 2021
Ruth L. Kirschstein National Research Service Award (NRSA) Institutional Research Training Grant (Parent T32)- PA-18-403 T32 November 21, 2017 January 8, 2021
Ruth L. Kirschstein National Research Service Award (NRSA) Short-Term Institutional Research Training Grant (Parent T35)- PA-18-404 T35 November 21, 2017 January 8, 2021
NIH Research Evaluation and Commercialization Hubs (REACH) Awards (U01 Clinical Trial Not Allowed)- RFA-OD-19-014 U01 December 17, 2018 March 20, 2019
Expanding Extramural Research Opportunities at the NIH Clinical Center (U01 Clinical Trial Optional)- PAR-18-879 U01 July 26, 2018 December 4, 2020
Computational Models of Immunity (U01 Clinical Trial Not Allowed)- RFA-AI-19-011 U01 January 30, 2019 June 11, 2019
NIAID Clinical Trial Implementation Cooperative Agreement (U01 Clinical Trial Required)- PAR-18-633 U01 February 6, 2018 January 14, 2021
Advancing mAbs to Achieve a Drug-free Sustained HIV Virologic Remission (U01 Clinical Trial Required)- RFA-AI-18-022 U01 June 28, 2018 October 10, 2019
Genetic Engineering Technologies for HIV Cure Research (U19 Clinical Trial Optional)- RFA-AI-18-058 U19 November 29, 2018 March 12, 2019
Centers for Medical Countermeasures Against Radiation Consortium (U19 Clinical Trial Not Allowed)- RFA-AI-19-012 U19 February 8, 2019 June 1, 2019
NIAID SBIR Phase II Clinical Trial Implementation Cooperative Agreement (U44 Clinical Trial Required)- PAR-18-632 U44 February 6, 2018 January 14, 2021
HIV/AIDS Adult Therapeutics Clinical Trials Network Leadership and Operations Center (UM1 Clinical Trial Required)- RFA-AI-19-003 UM1 January 24, 2019 August 2, 2019
HIV/AIDS Maternal, Adolescent and Pediatric Therapeutics Clinical Trials Network Leadership and Operations Center (UM1 Clinical Trial Required)- RFA-AI-19-004 UM1 January 24, 2019 August 2, 2019
HIV Prevention Clinical Trials Network Leadership and Operations Center (UM1 Clinical Trial Required)- RFA-AI-19-005 UM1 January 24, 2019 August 2, 2019
HIV Vaccines Clinical Trials Network Leadership and Operations Center (UM1 Clinical Trial Required)- RFA-AI-19-006 UM1 January 24, 2019 August 2, 2019
HIV/AIDS Clinical Trials Networks Laboratory Centers (UM1 Clinical Trial Required)- RFA-AI-19-001 UM1 January 24, 2019 August 2, 2019
HIV/AIDS Clinical Trials Networks Statistical and Data Management Centers (SDMC) (UM1 Clinical Trial Required)- RFA-AI-19-002 UM1 January 24, 2019 August 2, 2019